Edesa Biotech (EDSA) Misses Q2 EPS by 6c

Edesa Biotech (NASDAQ: EDSA) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• Nelson Peltz Prepares Bid For Wendy’s - FT
• Cisco Systems (CSCO) call put ratio 2.4 calls to 1 put into quarter results
• NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark